Hematologic Oncology Update, Issue 3, 2016 (Video Program) - Video 5

Case discussion: A 62-year-old man with chemotherapy-refractory diffuse large B-cell lymphoma whose disease is controlled with R2 achieves a complete response with chimeric antigen receptor T-cell (CAR-T) therapy
5:49 minutes.

Non-Hodgkin lymphoma (NHL), Hodgkin lymphoma and chronic lymphocytic leukemia (CLL)

Acute and chronic leukemias and myeloproliferative neoplasms

Multiple myeloma (MM)